Conatus Pharmaceuticals - 6 Year Stock Price History | CNAT

Historical daily share price chart and data for Conatus Pharmaceuticals since 2013 adjusted for splits. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Conatus Pharmaceuticals as of March 18, 2019 is 2.89.
Conatus Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 2.0640 1.8100 2.8900 1.7200 2.8900 67.05%
2018 4.5332 4.7500 7.5000 1.1700 1.7300 -62.55%
2017 5.3061 5.3900 8.7700 3.9200 4.6200 -12.33%
2016 2.1749 2.9300 6.1100 1.5000 5.2700 82.99%
2015 5.0474 8.0900 10.6300 2.5900 2.8800 -58.86%
2014 7.8589 6.2600 14.2500 5.3200 7.0000 8.53%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.081B $0.034B
Conatus Pharmaceuticals, Inc. is a biotechnology company. It is focused on developing and commercializing medicines to treat liver disease. The Company is developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. Conatus Pharmaceuticals, Inc. is headquartered in San Diego, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.272B 27.73
Medtronic (MDT) Ireland $125.787B 18.39
Stryker (SYK) United States $72.312B 26.54
Boston Scientific (BSX) United States $55.730B 27.17
Baxter (BAX) United States $39.435B 25.23
Zimmer Biomet Holdings (ZBH) United States $25.742B 16.48
Smith & Nephew SNATS (SNN) United Kingdom $17.346B 0.00
Canopy Growth (CGC) Canada $15.357B 0.00
ResMed (RMD) United States $14.383B 27.27
Aurora Cannabis (ACB) Canada $9.728B 68.64
Bio-Rad Laboratories (BIO) United States $9.298B 53.05
Hill-Rom Holdings (HRC) United States $6.949B 21.49
Perrigo (PRGO) Ireland $6.542B 10.61
Insulet (PODD) United States $5.812B 1960.80
GW Pharmaceuticals (GWPH) United Kingdom $5.107B 0.00
ICU Medical (ICUI) United States $4.771B 29.70
Haemonetics (HAE) United States $4.422B 39.23
Agios Pharmaceuticals (AGIO) United States $3.796B 0.00
Hutchison China MediTech (HCM) China $3.712B 0.00
Neogen (NEOG) United States $3.240B 49.77
NuVasive (NUVA) United States $2.859B 24.94
Quidel (QDEL) United States $2.688B 24.25
Aphria (APHA) $2.403B 106.67
National Vision Holdings (EYE) United States $2.385B 46.92
Cardiovascular Systems (CSII) United States $1.382B 992.25
Phibro Animal Health (PAHC) United States $1.275B 18.33
VAREX IMAGING (VREX) United States $1.255B 24.57
AtriCure (ATRC) United States $1.121B 0.00
MacroGenics (MGNX) United States $0.933B 0.00
Lantheus Holdings (LNTH) United States $0.929B 25.10
NanoString Technologies (NSTG) United States $0.855B 0.00
Cerus (CERS) United States $0.838B 0.00
PetIQ (PETQ) United States $0.787B 22.53
Omeros (OMER) United States $0.786B 0.00
OraSure Technologies (OSUR) United States $0.721B 31.62
Surmodics (SRDX) United States $0.703B 102.18
Meridian Bioscience (VIVO) United States $0.701B 20.89
Evolus (EOLS) United States $0.677B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.655B 22.28
LeMaitre Vascular (LMAT) United States $0.614B 29.22
TG Therapeutics (TGTX) United States $0.607B 0.00
Quanterix (QTRX) United States $0.552B 0.00
BioLife Solutions (BLFS) United States $0.346B 143.85
Vapotherm (VAPO) United States $0.335B 0.00
Utah Medical Products (UTMD) United States $0.323B 21.01
Insys Therapeutics (INSY) United States $0.308B 0.00
Owens & Minor (OMI) United States $0.301B 4.17
Rockwell Medical (RMTI) United States $0.297B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.269B 0.00
Bovie Medical (APYX) United States $0.263B 0.00
Cytosorbents (CTSO) United States $0.255B 0.00
Fonar (FONR) United States $0.146B 7.81
Zynex (ZYXI) United States $0.142B 15.14
Surface Oncology (SURF) United States $0.131B 0.00
Chimerix (CMRX) United States $0.104B 0.00
Chembio Diagnostics (CEMI) United States $0.101B 0.00
Female Health (VERU) United States $0.094B 0.00
United-Guardian (UG) United States $0.089B 18.64
Trinity Biotech (TRIB) Ireland $0.073B 21.79
CAS Medical Systems (CASM) United States $0.072B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Neurotrope (NTRP) United States $0.052B 0.00
Valeritas Holdings (VLRX) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Senestech (SNES) United States $0.026B 0.00
Capricor Therapeutics (CAPR) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.14